icon-    folder.gif   Conference Reports for NATAP  
  (APASL) 25th Conference of the Asian Pacific
Association for the Study of the Liver
Feb 20-24 2016, Tokyo, Japan

Back grey_arrow_rt.gif
Flares in patients treated with Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon (PEG)
  Reported by Jules Levin
APASL 2016 Tokyo Feb 20-24
HLY Chan1, SH Ahn 2, WL Chuang3, F Tabak4, R Mehta5, J Petersen6, K Kim7, P Dinh7, LJ Yee7, GM Subramanian7, HLA Janssen8, SG Lim9, S Fung10, GR Foster11, M Buti12, GB Gaeta13, AJ Hui14, G Papatheodoridis15, R Flisiak16, P Marcellin17
1The Chinese University of Hong Kong, Hong Kong; 2Yonsei University College of Medicine, Seoul, South Korea; 3Kaohsiung Medical University, Kaohsiung, Taiwan; 4Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; 5Liver Clinic, Surat, India; 6IFI Institute, Asklepios Klinik St. Georg University of Hamburg, Germany; 7Gilead Sciences, Inc., Foster City, California, USA;
8University of Toronto, Toronto Centre for Liver Disease, Canada; 9Yong Loo Lin School of Medicine, National University of Singapore; 10University of Toronto, Department of Medicine, Toronto General Hospital, Toronto, Canada; 11Queen Marys University of London, London; 12Hospital Universitari Vall d'Hebron, Barcelona, Spain; 13Second University of Naples, Italy; 14The Chinese University of Hong Kong, Hong Kong, China; Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China; 15Athens University Medical School, "Laiko" General Hospital of Athens, Athens, Greece; 16Medical University of Bialystok, Poland; 17Hopital Beaujon, University of Paris, Paris, France